CRNA — Circio Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK2.89bn
- NOK2.36bn
Brief: Targovax: Encouraging Survival Data For Oncos-102 In Mesothelioma
Brief: Targovax Not To Proceed With Subsequent Offering
Brief: Targovax: Contemplated Private Placement
Brief: Targovax Announces That ONCOS-102 And Durvalumab Trial Successfully Completes Part 1 In Colorectal Cancer
Brief: Targovax Granted European Patent For Oncos-102
Brief: Targovax Q2 Operating Loss Narrows To NOK 29.7 Mln
Brief: Targovax Enters Collaboration With Oblique
Brief: Targovax: Presentation Of Pre-Clinical Data From Next Generation ONCOS At AACR Virtual Annual Conference
Brief: Targovax Announces Collaborative Agreement With Merck & Co
Brief: Targovax's ONCOS-102 Mesothelioma 12-Month Data Demonstrate Broad Immune Activation Linked To Clinical Benefit
Brief: Targovax Enters Collaboration With Leidos
Brief: Targovax Q1 Operating Loss Narrows To NOK 29.3 Million
Brief: Targovax Releases Update For Mesothelioma Trial Combining ONCOS-102 And Chemotherapy
Brief: Targovax, Valo Therapeutics Enter Collaboration To Develop RAS
Brief: Targovax Announces Proposed New Chairman Of The Board
Brief: Targovax Updates On Impact Of Coronavirus On Its Operations
Brief: Targovax: Board Of Directors Resolves To Not Proceed With Subsequent Offering
Brief: Targovax Successfully Completed Private Placement
Brief: Targovax Contemplates Private Placement